Abstract
OS-085 - Use of antidiabetic and lipid-lowering medications associated with lower scores of liver fibrosis biomarkers in non-alcoholic steatohepatitis (NASH) patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have